Jardine Lloyd Thompson completes issue of private placement loan notes
Jardine Lloyd Thompson Group (JLT), an international group of risk specialists and employee benefits consultants, has announced the completion of a 250m dollar issue of private placement loan notes with institutional investors.
Jardine Lloyd Thompson Group (JLT), an international group of risk specialists and employee benefits consultants, has announced the completion of a 250m dollar issue of private placement loan notes with institutional investors.
The proceeds of the placement, which was "significantly oversubscribed", will be used to refinance existing shorter term borrowings under the group's revolving credit facilities with its relationship banks.
The firm said the notes were issued by its wholly-owned subsidiary, JIB Group, mainly to existing investors and consist of $40m seven year notes with a coupon of 3.21%, $140m 10-year notes with a coupon of 3.78%, and $70m 12-year notes with a coupon of 3.93%.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Michael Reynolds, Group Finance Director said: 'We are delighted with the success of this transaction and with the positive response from our investors, which reflects the continued strength of JLT's business and credit profile.
"This second private placement issue further demonstrates the confidence of our debt investors in JLT and secures additional committed longer-term funding for the Group. This provides additional headroom and flexibility to support our ongoing growth as we continue to implement our strategy."
The share price dipped 0.51% to 783p by 08:34.
NR
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Thousands of Brits switch to Nationwide, Monzo and HSBC – which banks are least popular?
As current account bank switches reach a record high, we look at the most and least popular banks and building societies among Brits. Is it worth switching?
-
Are these FTSE 100 pharmaceutical stocks worth a look?
Pharmaceutical stocks are some of the biggest in the FTSE 100. The sector is threatened by tariffs, but some have posted encouraging results regardless.